TMCO1 expression promotes cell proliferation and induces epithelial–mesenchymal transformation in human gliomas

[1]  Jian Sun,et al.  Calreticulin promotes EMT in pancreatic cancer via mediating Ca2+ dependent acute and chronic endoplasmic reticulum stress , 2020, Journal of experimental & clinical cancer research : CR.

[2]  Rongxin Geng,et al.  AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway , 2020, Frontiers in Pharmacology.

[3]  H. Liu,et al.  Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy , 2019, Molecular Cancer.

[4]  J. Qin,et al.  TMCO1-mediated Ca2+ leak underlies osteoblast functions via CaMKII signaling , 2019, Nature Communications.

[5]  S. Di Bartolomeo,et al.  EMT Regulation by Autophagy: A New Perspective in Glioblastoma Biology , 2019, Cancers.

[6]  Helen Y Wang,et al.  Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma , 2018, Front. Immunol..

[7]  C. Bettegowda,et al.  Current state of immunotherapy for glioblastoma , 2018, Nature Reviews Clinical Oncology.

[8]  G. Monteith,et al.  Calcium signaling and the therapeutic targeting of cancer cells. , 2018, Biochimica et biophysica acta. Molecular cell research.

[9]  Jiu-qiang Wang,et al.  TMCO1 is essential for ovarian follicle development by regulating ER Ca2+ store of granulosa cells , 2018, Cell Death & Differentiation.

[10]  L. Ming,et al.  SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells , 2018, Cell Death & Disease.

[11]  M. Hegi,et al.  Glioma epigenetics: From subclassification to novel treatment options. , 2017, Seminars in cancer biology.

[12]  E. Hulleman,et al.  Signaling pathways and mesenchymal transition in pediatric high-grade glioma , 2017, Cellular and Molecular Life Sciences.

[13]  Wen-Ren Wu,et al.  Transmembrane and Coiled-Coil Domain 1 Impairs the AKT Signaling Pathway in Urinary Bladder Urothelial Carcinoma: A Characterization of a Tumor Suppressor , 2017, Clinical Cancer Research.

[14]  Qianshan Ding,et al.  SSRP1 silencing inhibits the proliferation and malignancy of human glioma cells via the MAPK signaling pathway , 2017, Oncology reports.

[15]  Hong Liu,et al.  SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells , 2017, Autophagy.

[16]  R. Verhaak,et al.  GlioVis data portal for visualization and analysis of brain tumor expression datasets. , 2017, Neuro-oncology.

[17]  Quan Chen,et al.  TMCO1 Is an ER Ca2+ Load-Activated Ca2+ Channel , 2016, Cell.

[18]  P. McCrea,et al.  Beyond β-catenin: prospects for a larger catenin network in the nucleus , 2015, Nature Reviews Molecular Cell Biology.

[19]  Jean Paul Thiery,et al.  EMT: 2016 , 2016, Cell.

[20]  Rebecca SY Wong,et al.  Apoptosis in cancer: from pathogenesis to treatment , 2011, Journal of experimental & clinical cancer research : CR.

[21]  T. Barrette,et al.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.